VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NBTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NBTXNanobiotix S.A.
$41.10$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNBTXQuarterly Financials

Nanobiotix S.A. (NBTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nanobiotix S.A. (NBTX) quarterly income statement — complete revenue, gross profit & net income history

NBTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16Q2'16
Sales/Revenue3M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M718K1.82M1.42M2.06M1.84M1.88M2.39M3.04M
Revenue Growth %118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%-49.4%-11.5%-22.87%9.45%-22.89%-38%1.26%82.98%
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit3M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M718K1.82M1.42M2.06M1.84M1.88M2.39M3.04M
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%-49.4%-11.5%-22.87%9.45%-22.89%-38%1.26%82.98%
Operating Expenses14.63M25.83M28.26M32.94M34.32M28.66M24.27M27.21M24.13M31.1M18.92M19.83M27.03M22.29M18.51M15.04M15.3M13.69M14.17M13.11M
OpEx % of Revenue486.89%96.97%-171.5%354.62%104.28%870.42%704.15%2047.1%1816.94%2357.62%2157.47%1369.61%3764.62%1222.71%1304.37%729.95%831.63%727.27%593.76%431.85%
Selling, General & Admin8.93M11.29M9.69M10.82M11.19M10.86M8.22M9.64M9.26M10.18M7.86M6.75M10M8.91M6.45M6.2M4.81M6.45M5.46M4.9M
SG&A % of Revenue297.1%42.4%-58.83%116.47%33.98%329.91%238.5%725.06%697.14%771.49%895.78%466.51%1392.62%488.75%454.76%300.97%261.17%342.68%228.9%161.4%
Research & Development8.59M14.53M18.55M21.99M20.59M17.8M16.03M16.61M14.87M15.51M11.25M13.08M17.03M13.38M12.06M8.84M10.49M7.24M8.71M8.21M
R&D % of Revenue285.72%54.54%-112.59%236.7%62.56%540.69%464.98%1249.66%1119.88%1175.59%1283.12%903.11%2372.01%733.96%849.68%428.98%570.4%384.59%364.86%270.44%
Other Operating Expenses-1000K7K13K135K1000K-6K23K962K-1K1000K-188K000-1K01K000
Operating Income-11.63M808K-44.74M-23.65M-1.41M-25.37M-20.82M-25.88M-22.8M-29.78M-18.04M-18.38M-26.31M-20.47M-17.09M-12.98M-13.46M-11.81M-11.78M-10.07M
Operating Margin %-386.89%3.03%271.5%-254.62%-4.28%-770.42%-604.15%-1947.1%-1716.94%-2257.62%-2057.47%-1269.61%-3664.62%-1122.71%-1204.37%-629.95%-731.63%-627.27%-493.76%-331.85%
Operating Income Growth %74.01%103.42%-3075.3%6.77%93.23%1.96%8.67%13.1%-26.36%-61.98%31.42%10.18%-53.96%-57.72%-26.96%-9.92%-14.26%-17.2%-27.1%-27.96%
EBITDA-10.41M1.08M-44.44M-22.87M-637K-24.63M-20.07M-25.13M-22.04M-28.98M-17.2M-17.48M-25.19M-19.62M-16.86M-12.68M-13.16M-11.65M-11.55M-9.82M
EBITDA Margin %-346.32%4.07%269.65%-246.16%-1.94%-747.92%-582.27%-1890.97%-1659.79%-2196.89%-1960.78%-1207.04%-3508.91%-1076.08%-1187.88%-615.63%-715.23%-619.18%-484.15%-323.49%
EBITDA Growth %76.58%104.74%-6875.67%7.16%96.83%2%8.94%13.27%-28.18%-65.79%31.75%10.9%-49.47%-54.68%-28.09%-8.82%-13.91%-18.68%-28.75%-27.31%
D&A (Non-Cash Add-back)1.22M276K305K786K772K741K754K746K759K801K848K906K1.12M850K234K295K301.78K152.22K229.18K253.61K
EBIT-14.38M815K-44.73M-23.52M1.14M-25.38M-20.8M-24.92M-22.8M-24.36M-18.23M-18.38M-26.31M-20.47M-17.09M-12.98M-13.46M-11.81M-11.78M-10.07M
Net Interest Income-5.76M-3.65M00-3.4M-3.37M-2.86M1.36M1.22M1.56M1.03M-1.19M458.5K-712.7K000000
Interest Income985K00000250K1.36M1.22M1.56M1.03M0458.5K20.87K640K173K36.95K38.05K28.58K14.13K
Interest Expense6.75M3.65M003.4M3.37M3.11M00001.19M0733.57K000000
Other Income/Expense-6.96M-6.18M-1.56M1.92M-10.07M-2.73M-9.86M-474K6.22M-640K5.04M-2.2M-680K-3.45M-640K362K-492.39K-383.61K70.42K-5.82K
Pretax Income-18.58M-5.38M-46.3M-21.73M-11.48M-28.1M-30.68M-26.35M-16.58M-30.42M-13M-20.58M-26.99M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M-10.08M
Pretax Margin %-618.34%-20.19%280.98%-233.91%-34.89%-853.2%-890.05%-1982.77%-1248.49%-2306.14%-1482.44%-1421.27%-3759.33%-1312.12%-1249.47%-612.38%-758.39%-647.65%-490.8%-332.04%
Income Tax-3K6K-43K144K117K3K4K6K3K2K10K1K3K000212196989.46K
Effective Tax Rate %0.02%-0.11%0.09%-0.66%-1.02%-0.01%-0.01%-0.02%-0.02%-0.01%-0.08%-0%-0.01%0%0%0%-0%-0%-0.01%-0.89%
Net Income-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M-27M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M-10.17M
Net Margin %-618.24%-20.21%280.72%-235.46%-35.25%-853.29%-890.17%-1983.22%-1248.72%-2306.29%-1483.58%-1421.2%-3759.75%-1312.12%-1249.47%-612.38%-758.39%-647.65%-490.85%-334.99%
Net Income Growth %59.84%75.39%-298.76%22.16%62.19%-6.61%-85.03%13.36%-27.45%-47.82%51.8%13.97%-52.26%-89.62%-27.07%-3.49%-19.14%-19.87%-26.89%-30.81%
Net Income (Continuing)-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M-27M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M-10.17M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.39-0.11-0.98-0.46-0.31-0.80-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.90-0.64-0.74-0.76-0.76-0.68
EPS Growth %60.2%76.09%-216.13%42.5%64.77%-5.26%-83.33%13.64%-2.13%3.3%61.16%20.87%-34.44%-79.69%-21.62%15.79%2.63%-11.76%-8.57%-30.77%
EPS (Basic)-0.39-0.11-0.98-0.46-0.30-0.80-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.92-0.64-0.74-0.76-0.76-0.68
Diluted Shares Outstanding47.82M47.42M47.27M47.12M38.82M35.04M34.85M34.84M34.81M34.62M27.85M22.61M22.38M20.84M19.63M19.63M18.94M16.04M15.6M14.95M
Basic Shares Outstanding47.82M47.42M47.27M47.12M37.99M35.04M34.85M34.84M34.81M34.62M27.85M22.61M22.38M20.84M19.48M19.63M18.83M16.04M15.6M14.95M
Dividend Payout Ratio--------------------